These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 25910758)

  • 1. MicroRNA as tools and therapeutics in lung cancer.
    Barger JF; Nana-Sinkam SP
    Respir Med; 2015 Jul; 109(7):803-12. PubMed ID: 25910758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.
    Kunz M; Göttlich C; Walles T; Nietzer S; Dandekar G; Dandekar T
    Tumour Biol; 2017 Jul; 39(7):1010428317706430. PubMed ID: 28705115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA and Lung Cancer.
    Del Vescovo V; Denti MA
    Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer.
    Zhou R; Zhou X; Yin Z; Guo J; Hu T; Jiang S; Liu L; Dong X; Zhang S; Wu G
    Oncotarget; 2015 Dec; 6(42):44609-22. PubMed ID: 26587830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of circulating miRNA detection in lung cancer.
    Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
    Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA as a new factor in lung and esophageal cancer.
    Billeter AT; Barnett RE; Druen D; Polk HC; van Berkel VH
    Semin Thorac Cardiovasc Surg; 2012; 24(3):155-65. PubMed ID: 23200070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.
    Iqbal MA; Arora S; Prakasam G; Calin GA; Syed MA
    Mol Aspects Med; 2019 Dec; 70():3-20. PubMed ID: 30102929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection.
    Song T; Liang Y; Cao Z; Du W; Li Y
    Biomed Res Int; 2017; 2017():4680650. PubMed ID: 28357401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of MicroRNA in Lung Cancer.
    Wu KL; Tsai YM; Lien CT; Kuo PL; Hung AJ
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30935143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
    Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
    Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.
    Wang J; Du Y; Liu X; Cho WC; Yang Y
    Biomed Res Int; 2015; 2015():823620. PubMed ID: 26064956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.